Report of the Independent Allocation of Vaccines Group on the allocation of COVAX Facility secured vaccines: 22 February 2021

Overview

This report covers the first Allocation of Astra Zeneca vaccines produced at the following two sites for which WHO issued an Emergency Use Listing on 15 February 2021:

• Serum Institute of India Pvt Ltd - COVID-19 Vaccine (ChAdOx1-S [recombinant]) - COVISHIELD™ - “SII AZ”
• AstraZeneca/SKBio - COVID-19 Vaccine (ChAdOx1-S [recombinant]) - “AZ”